BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23371256)

  • 1. [Personalized therapy].
    Hallek M; Wolf J
    Internist (Berl); 2013 Feb; 54(2):145-6. PubMed ID: 23371256
    [No Abstract]   [Full Text] [Related]  

  • 2. Personalized medicine: the medicine of tomorrow. Foreword.
    Tremblay-Servier M
    Metabolism; 2013 Jan; 62 Suppl 1():S1. PubMed ID: 23018144
    [No Abstract]   [Full Text] [Related]  

  • 3. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From next-generation sequencing to nanopore sequencing technology: paving the way to personalized genomic medicine.
    Ku CS; Roukos DH
    Expert Rev Med Devices; 2013 Jan; 10(1):1-6. PubMed ID: 23278216
    [No Abstract]   [Full Text] [Related]  

  • 5. Prospects of personalized medicine in cardiovascular diseases.
    Lenfant C
    Metabolism; 2013 Jan; 62 Suppl 1():S6-10. PubMed ID: 22999711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personalizing medicine for the child with heart disease: a path forward.
    Mital S
    J Cardiovasc Pharmacol; 2011 Jul; 58(1):1-3. PubMed ID: 21654326
    [No Abstract]   [Full Text] [Related]  

  • 7. Genomics, personalized medicine and cancer practice.
    Dancey J
    Clin Biochem; 2012 Apr; 45(6):379-81. PubMed ID: 22424082
    [No Abstract]   [Full Text] [Related]  

  • 8. Sequencing set to alter clinical landscape.
    Hayden EC
    Nature; 2012 Feb; 482(7385):288. PubMed ID: 22337027
    [No Abstract]   [Full Text] [Related]  

  • 9. Biomarkers and oncology: the path forward to a learning health system.
    Yu PP; Hoffman MA; Hayes DF
    Arch Pathol Lab Med; 2015 Apr; 139(4):451-6. PubMed ID: 25152310
    [No Abstract]   [Full Text] [Related]  

  • 10. [Targeted therapy of a cancer patient is multiprofessional collaboration].
    Ristimäki A; Kytölä S; Haglund C; Bono P
    Duodecim; 2013; 129(10):1071-9. PubMed ID: 23767137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of genomics on personalized cancer medicine.
    Arteaga CL; Baselga J
    Clin Cancer Res; 2012 Feb; 18(3):612-8. PubMed ID: 22298893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research impulses for personalized cancer therapies].
    Aktuelle Urol; 2013 Sep; 44(5):349. PubMed ID: 24043531
    [No Abstract]   [Full Text] [Related]  

  • 13. [Research projects for implementation of individualized medicine].
    Lieb W; Grabe HJ; Kroemer HK
    Dtsch Med Wochenschr; 2013 Mar; 138(13):665-6. PubMed ID: 23512371
    [No Abstract]   [Full Text] [Related]  

  • 14. NCI-MATCH launch highlights new trial design in precision-medicine era.
    McNeil C
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 26142446
    [No Abstract]   [Full Text] [Related]  

  • 15. [Personalized medicine 2011].
    Blum HE
    Dtsch Med Wochenschr; 2011 Mar; 136(10):459-60. PubMed ID: 21365521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Potential and perspective of genetic testing in Renaissance of laboratory medicine].
    Nobori T
    Rinsho Byori; 2013 Aug; 61(8):693-9. PubMed ID: 24218766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Making personalized cancer medicine a reality: challenges and opportunities in the development of biomarkers and companion diagnostics.
    Parkinson DR; Johnson BE; Sledge GW
    Clin Cancer Res; 2012 Feb; 18(3):619-24. PubMed ID: 22298894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Personalized therapeutic targeting by exome analysis].
    Lamy A; Angot E; Sabourin JC
    Ann Pathol; 2012 Nov; 32(5 Suppl):S44-5. PubMed ID: 23127937
    [No Abstract]   [Full Text] [Related]  

  • 19. Progress towards personalized medicine.
    Bates S
    Drug Discov Today; 2010 Feb; 15(3-4):115-20. PubMed ID: 19914397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalized medicine benefits patients in early trials: matching targeted therapies with gene mutations is associated with better outcomes, even in phase 1 studies.
    Printz C
    Cancer; 2012 Oct; 118(20):4911-2. PubMed ID: 23042614
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.